Pressure Biosciences Inc
(PBIO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Sales | 534 | 268 | 254 | 280 | 501 |
| Cost of Goods | 247 | 135 | 175 | 297 | 286 |
| Gross Profit | 287 | 133 | 79 | -18 | 215 |
| Operating Expenses | 1,353 | 1,599 | 1,649 | 2,219 | 1,570 |
| Operating Income | -819 | -1,331 | -1,395 | -1,939 | -1,069 |
| Interest Expense | 2,205 | 1,725 | 1,572 | 1,570 | 2,125 |
| Other Income | -255 | -1,513 | -987 | -173 | -181 |
| Pre-tax Income | -3,279 | -4,569 | -3,954 | -3,682 | -3,374 |
| Income Tax | N/A | N/A | N/A | N/A | -217 |
| Net Income Continuous | -3,279 | -4,569 | -3,954 | -3,682 | -3,157 |
| Net Income | $-3,279 | $-4,569 | $-3,954 | $-3,682 | $-3,157 |
| EPS Basic Total Ops | -1.02 | -0.17 | -1.62 | -1.55 | -2.20 |
| EPS Basic Continuous Ops | -0.91 | -1.57 | -1.49 | -1.56 | -1.60 |
| EPS Diluted Total Ops | -1.02 | -0.17 | -1.62 | -1.55 | -2.20 |
| EPS Diluted Continuous Ops | -0.91 | -1.57 | -1.49 | -1.56 | -1.60 |
| EBITDA(a) | $914 | $-429 | $-472 | $-1,418 | $-450 |